Total planned funding: $302,996,719
Allocations
Countries/Regions
Eswatini | $302,996,719 |
Organizational Types
Private Contractor | $82,797,678 |
NGO | $55,320,002 |
University | $53,120,611 |
Unknown | $46,614,536 |
Own Agency | $33,823,232 |
FBO | $13,230,009 |
Host Country Government Agency | $10,084,827 |
Multi-lateral Agency | $7,002,970 |
Other USG Agency | $1,002,854 |
Program Areas
Care | $93,077,223 |
Treatment | $82,086,932 |
Prevention | $58,302,270 |
Testing | $25,601,461 |
Governance and Systems | $24,144,010 |
Management and Operations | $19,784,823 |
Budget Codes
HTXS: Treatment: Adult Treatment | $66,859,430 |
HBHC: Care: Adult Care and Support | $41,256,466 |
HKID: Care: Orphans and Vulnerable Children | $32,810,412 |
HVCT: Testing: HIV Testing and Counseling | $25,601,461 |
HVOP: Sexual Prevention: Other Sexual Prevention | $23,373,468 |
HVMS: Management and Operations | $19,784,823 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $19,648,572 |
HVTB: Care: TB/HIV | $11,831,548 |
OHSS: Health Systems Strengthening | $10,159,906 |
HVSI: Strategic Information | $10,046,306 |
HTXD: Treatment: ARV Drugs | $9,448,189 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,768,883 |
PDCS: Care: Pediatric Care and Support | $7,178,797 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,866,376 |
PDTX: Treatment: Pediatric Treatment | $5,779,313 |
HLAB: Laboratory Infrastructure | $3,937,798 |
HMBL: Biomedical Prevention: Blood Safety | $644,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$44,007,235
Countries/Regions
Pact, Inc.:
$36,650,668
Countries/Regions
Not Available:
$28,304,670
Countries/Regions
Chemonics International:
$22,700,973
Countries/Regions